|
Press
Release
| Osmetech plc signs major commercial
agreements for OPTI with IDEXX -
06 August 2004 |
Osmetech plc signs major
commercial agreements for OPTI with IDEXX, a world leader
in animal health diagnostics
Osmetech plc (“Osmetech”),
the AIM-listed international diagnostics group, has entered
into an OEM (Original Equipment Manufacturer) agreement to
provide its OPTI blood gas analysers, customized for the veterinary
field, to IDEXX Laboratories Inc. (NASDAQ: IDXX).
In a second agreement Osmetech has entered into
a development and supply contract with IDEXX to create a new
platform for measuring critical care parameters based on Osmetech’s
proprietary optical fluorescence technology.
The contracts will be for a period of at least
10 years and will open the veterinarian market for Osmetech’s
technology and products.
OPTI product sales under the OEM agreement should
commence in the second half of the current financial year
and should make an initial contribution to Osmetech’s
overall sales revenues. The impact upon the next financial
year should be significant and sales should continue to build
in the medium term as the installed base of instruments expands
allowing considerable consumable revenues to be generated.
The development contract represents the first
stage of a commitment from IDEXX to incorporate the OPTI technology
into future new product platforms, which we also believe will
have a significant impact upon Osmetech’s sales revenues
in the medium term.
IDEXX is a worldwide leader in the development
and commercialisation of animal health diagnostic products,
delivering sales of $475 million in 2003 and with a market
capitalisation of approximately $1.8 billion.
James White, CEO of Osmetech said:
‘The long term commercial relationship
with IDEXX should provide a substantial level of new business
for OPTI both in terms of instrument sales and ongoing revenues
derived from sales of our proprietary consumables.
‘This relationship is not only a further
validation of the OPTI technology but also demonstrates our
capacity to scale up the Atlanta manufacturing infrastructure,
and benefit from providing higher volumes of top quality critical
care diagnostic instrumentation.
Ends
For further information:
James White, David Sandilands
Osmetech plc 44 (207) 378 7033
Matthew Moth
madano partnership 44 (207) 378 7033
Notes to editors:
IDEXX LABORATORIES INC
IDEXX Laboratories, Inc., is a worldwide leader in the development
and commercialization of innovative, technology-based products
and services for veterinary, food and water applications.
The Company's largest business is focused on companion animal
health, combining biotechnology, medical device technology
and information technology to aid veterinarians in providing
better medicine while building successful practices. IDEXX
Laboratories' food and water businesses are focused on employing
innovative technologies to monitor production animal health
and the safety and quality of drinking water and milk. Headquartered
in Westbrook, Maine, IDEXX Laboratories employs more than
2,500 people and offers products to customers in over
100 countries.
|